Form 4: Inari Medical CEO Andrew Hykes Exercises Stock Options, Reports Beneficial Ownership Changes

Sentiment:

SEC Form 4 Filing


Inari Medical's CEO, Andrew Hykes, executed stock options and reported changes in his beneficial ownership of the company's stock on February 10, 2025.

Summary

  • On February 10, 2025, Andrew Hykes, the President and CEO of Inari Medical, Inc., exercised stock options.
  • These transactions involved the acquisition of common stock at prices of $0.4284, $6.4546, and $0.4569 per share.
  • Following these transactions, Hykes directly owns 697,244 shares of common stock.
  • He also has indirect ownership through his children and spouse.
  • The exercised stock options had various vesting schedules, with full vesting occurring on March 29, 2022, January 1, 2024, and January 1, 2023.

Sentiment

Score: 5

Explanation: This is a neutral reporting of stock option exercises, neither inherently positive nor negative.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding executive compensation and ownership.
  • It has a limited impact on employees, customers, suppliers, and creditors.

Key Dates

DateDescription
March 29, 2022Stock option 1 became fully vested and exercisable.
January 1, 2023Stock option 3 became fully vested and exercisable.
January 1, 2024Stock option 2 became fully vested and exercisable.
February 10, 2025Date of the stock option exercises and reported transactions.
February 12, 2025Date of signature for the Form 4 filing.
May 03, 2028Expiration date of stock option 1.
March 12, 2029Expiration date of stock option 3.
January 17, 2030Expiration date of stock option 2.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.